61 / 490
SATURDAY 30 APRIL 2016
59
SCIENTIFIC PROGRAMME
| PROGRAMME AND EXHIBITION GUIDE
Teaching Lecture
CHALLENGES INMR GUIDED RADIOTHERAPY
08:00 - 08:40 | ROOM 1
Chair: C. Kirisits (Austria)
08:00 > Challenges in MR guided radiotherapy
Speaker: J. Jonsson (Sweden)
SP-0006
Teaching Lecture
PATIENT SPECIFIC QUALITY ASSURANCE IN PROTON THERAPY
08:00 - 08:40 | ROOM 500
Chair: S. Molinelli (Italy)
08:00 > Patient specific quality assurance in proton therapy
Speaker: R. Amos (UK)
SP-0007
Teaching Lecture
BALANCING TOXICITY AND DISEASE CONTROL IN THE EVOLUTION OF
RADIOTHERAPY TECHNOLOGY
08:00 - 08:40 | ROOM 3
Chair: A. Vaandering (Belgium)
08:00 > Balancing toxicity and disease control in the evolution
of radiotherapy technology
Speaker: B. O’Sullivan (Canada)
SP-0008
Symposium
SELECTION OF PATIENTS FOR PROTON THERAPY
08:45 - 10:00 | ROOM 2
This session will provide three different views on how to select the patients for proton therapy. Proton
therapy is not magic and proton therapy risk within the target volume is identical to other radiation
therapies, the differences are most often in the intermediate and low dose volumes outside the target.
Comparative treatment planning is essential and it should be free from observer bias. Automated
treatment planning and robust optimisation techniques should be considered. NTCP modeling is sug-
gested as an unbiased method for patient selection. Differences in DVHs (Δdose) require translation
into clinical effects (ΔNTCP) to become clinically meaningful..
Chair: M. Hoyer (Denmark)
Co-Chair: M. Ciocca (Italy)
08:45 > Patient selection for proton therapy: a clinicians view
Speaker: A. Mahajan (USA)
SP-0009
09:10 > Selection of patients for proton therapy: a physicists view
Speaker: M. Hoogeman (The Netherlands)
SP-0010